Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001079973-11-000912
Filing Date
2011-11-14
Accepted
2011-11-14 16:43:17
Documents
9
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q appy_10q-093011.htm 10-Q 707822
2 EXHIBIT 31.1 ex31x1.htm EX-31.1 15322
3 EXHIBIT 31.2 ex31x2.htm EX-31.2 16366
4 EXHIBIT 32 ex32.htm EX-32 12604
  Complete submission text file 0001079973-11-000912.txt   2449943

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT appy-20110930.xml EX-101.INS 354708
6 XBRL TAXONOMY EXTENSION SCHEMA appy-20110930.xsd EX-101.SCH 10690
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE appy-20110930_cal.xml EX-101.CAL 31726
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE appy-20110930_lab.xml EX-101.LAB 121629
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE appy-20110930_pre.xml EX-101.PRE 70216
Mailing Address 1585 S. PERRY STREET CASTLE ROCK CO 80104
Business Address 1585 S. PERRY STREET CASTLE ROCK CO 80104 (303) 794-2000
AspenBio Pharma, Inc. (Filer) CIK: 0001167419 (see all company filings)

EIN.: 841553387 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33675 | Film No.: 111203502
SIC: 2835 In Vitro & In Vivo Diagnostic Substances